Options for pharmacologic, liver-targeted therapy for NAFLD are limited (eg, vitamin E, some insulin sensitizers), and we do not use them in all patients. We reserve pharmacologic therapy for patients who do not achieve their weight loss goals and who have biopsy-proven NASH with fibrosis stage ≥2. The approach also depends on whether the patient has diabetes mellitus.
Related Posts
